Tech Company Financing Transactions
OPX Biotechnologies Funding Round
OPX Biotechnologies closed a $3.6 million Series A funding round on 12/5/2007. Investors included Mohr Davidow Ventures and XSeed Capital.
Transaction Overview
Company Name
Announced On
12/5/2007
Transaction Type
Venture Equity
Amount
$3,600,000
Round
Series A
Investors
Mohr Davidow Ventures (Lead Investor) (Erik Straser)
XSeed Capital (Michael Borrus)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2425 55th St. 100
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Not Recorded
Overview
OPX Biotechnologies, Inc. is a new company dedicated to enabling renewable fuels and chemicals that are economically and environmentally superior to petroleum-based products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David MacLennan
Browse more venture capital transactions:
Prev: 12/5/2007: CardioMEMS venture capital transaction
Next: 12/5/2007: TuVox venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs